ArticleResearch synthesis methods2025
One-step parametric network meta-analysis models using the exact likelihood that allow for time-varying treatment effects.
Article in Research synthesis methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Network Meta-Analysis of Survival Outcomes With Non-Proportional Hazards Using Flexible M-Splines.Statistics in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The importance of network meta-analysis (NMA) methods for time-to-event (TTE) that do not rely on the proportional hazard (PH) assumption is increasingly recognized in oncology, where clinical trials evaluating new interventions versus standard comparators often violate this assumption. However, existing NMA methods that allow for time-varying treatment effects do not directly leverage individual events and censor times that can be reconstructed from Kaplan-Meier curves, which may be more accurate than discrete hazards. They are also challenging to implement given reparameterizations that rely on discrete hazards. Additionally, two-step methods require assumptions regarding within-study normality and variance. We propose a one-step fully Bayesian parametric individual patient data (IPD)-NMA model that fits TTE data with the exact likelihood and allows for time-varying treatment effects. We define fixed or random effects with the following distributions: Weibull, Gompertz, log-normal, log-logistic, gamma, or generalized gamma distributions. We apply the one-step model to a network of randomized controlled trials (RCTs) evaluating multiple interventions for advanced melanoma and compare results with those obtained with the two-step approach. Additionally, a simulation study was performed to compare the proposed one-step method to the two-step method. The one-step method allows for straightforward model selection among the "standard" distributions, now including gamma and generalized gamma, with treatment effects on either the scale alone or with multivariate treatment effects. Generalized gamma offers flexibility to model U-shaped hazards within a network of RCTs, with accessible interpretation of parameters that simplifies to exponential, Weibull, log-normal, or gamma in special cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.